Business

Photo

Wall St. rises on earnings; on track to snap four-week drop

NEW YORK - U.S. stocks advanced on Friday, as earnings from Microsoft and Procter & Gamble and easing concerns over the possible spread of Ebola in the United States helped put the S&P on track to snap a four-week losing skid.

Recent Business News

Deutsche Bank braces for $1.3 billion in U.S., UK Libor fines: sources

FRANKFURT - Deutsche Bank is bracing to pay almost 1 billion euros ($1.3 billion) for Libor-related fines as it nears a deal with U.S. and UK authorities to settle allegations it attempted to manipulate the benchmark interest rate, two sources familiar with the matter said on Friday.

UPS may hike charges for major customers for holiday package surges

CHICAGO - United Parcel Service Inc may charge major customers more for a surge in late, unplanned packages or turn down the business if it threatens disruptions during the peak holiday season, a top executive said on Friday, trying to avoid a repeat of last year's delivery meltdown.

11:41am EDT

Chesapeake Oilfield Services pulls IPO plans

- Chesapeake Oilfield Services, a unit of Chesapeake Energy Corp , said on Friday it would withdraw its plans for an initial public offering.

Deals, Chesapeake Energy 11:04am EDT

Port squeeze threatens U.S. retailers' holiday stocking plans

CHICAGO/LOS ANGELES - A shortage of transportation equipment and possible labor disruptions at ‚Äčthe Los Angeles/Long Beach port complex, ‚Äčthe nation's busiest, is delaying shipping containers for up to three weeks, threatening timely delivery to retailers for the holiday season.

11:50am EDT

P&G to exit Duracell battery business; quarterly sales dip

- Procter & Gamble Co on Friday said it would sell its Duracell battery business, probably through a split-off into a separate company, as it looks to focus on faster-growing brands.

12:26pm EDT

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Big Pharma’s race to develop an Ebola vaccine

the World Health Organization made real news this week as it announced large-scale clinical trials, due to start in January, 2015, in the rush to vaccinate against the further spread of Ebola in West Africa.